The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpax Asset Management Regulatory News (IPX)

Share Price Information for Impax Asset Management (IPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 469.00
Bid: 467.00
Ask: 469.50
Change: 4.00 (0.86%)
Spread: 2.50 (0.535%)
Open: 468.00
High: 475.50
Low: 466.00
Prev. Close: 465.00
IPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Mondi Plc

26 Mar 2024 14:32

RNS Number : 3814I
Impax Asset Management Ltd
26 March 2024

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Full name of discloser:

Impax Asset Management Group

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Not applicable

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mondi Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

Not applicable

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

25 March 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

GB00BMWC6P49 (EUR 0.22 ordinary)

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

5,533,448

1.25

Not applicable

(2) Cash-settled derivatives:

Not applicable

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Not applicable

TOTAL:

5,533,448*

1.25

*Change in holding of 113 shares since the last disclosure on 25th March 2024 is in part due to the transfer out of a discretionary holding.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

EUR 0.22 ordinary

GB00BMWC6P49

Purchase

495

GBP 13.64

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

None

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

None

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

None

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

None

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

26th March 2024

Contact name:

Rose Ackerman

Telephone number*:

+44 20 3912 3033

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RETEALDKADELEFA
Date   Source Headline
18th Apr 20196:19 pmRNSDirector/PDMR Shareholding
17th Apr 20195:31 pmRNSDirector/PDMR Shareholding
17th Apr 20198:56 amRNSDirector/PDMR Shareholding
8th Apr 20197:00 amRNSAUM Update
15th Mar 20194:54 pmRNSDirector/PDMR Shareholding
7th Mar 20194:04 pmRNSResult of AGM
4th Mar 20197:00 amRNSRelated Party Transaction
14th Feb 20194:36 pmRNSHolding(s) in Company - Replacement
13th Feb 20192:05 pmRNSHolding(s) in Company
8th Feb 201912:09 pmRNSResult of Placing in Impax Asset Management Group
10th Jan 20197:00 amRNSDirector/PDMR Shareholding
7th Jan 20197:00 amRNSAUM update
17th Dec 20184:20 pmRNSNotice of Annual General Meeting ("AGM")
10th Dec 20182:03 pmRNSDirector/PDMR Shareholding
7th Dec 20183:36 pmRNSAnnual Financial Report
6th Dec 20187:00 amRNSFinal Results
21st Nov 20184:52 pmRNSNotice of Results
5th Nov 20183:55 pmRNSRecommendation to Trustees of EBT
9th Oct 20187:00 amRNSRelated Party Transaction
8th Oct 20187:00 amRNSAUM update
12th Sep 201810:31 amRNSHolding(s) in Company - Replacement
11th Sep 20183:59 pmRNSHolding(s) in Company
11th Jul 20182:00 pmRNSHolding(s) in Company
11th Jul 20181:56 pmRNSHolding(s) in Company
10th Jul 20182:03 pmRNSDirector/PDMR Shareholding
6th Jul 20187:00 amRNSAUM update
18th Jun 201812:38 pmRNSDirector/PDMR and PCA Shareholding
12th Jun 201810:54 amRNSDirectorate Change
7th Jun 20187:56 amRNSInterim results to 31 March 2018
4th May 20181:30 pmRNSRecommendation to Trustees of EBT
25th Apr 20187:00 amRNSNotice of Results
23rd Apr 20186:01 pmRNSHolding(s) in Company
23rd Apr 201811:43 amRNSHolding(s) in Company
16th Apr 20186:25 pmRNSDirector/PDMR Shareholding
11th Apr 20187:00 amRNSShare Incentive Plan
10th Apr 20187:00 amRNSAUM update
27th Mar 20186:21 pmRNSDirector/PDMR/PCA Shareholding
2nd Mar 20181:31 pmRNSResult of AGM
2nd Mar 20187:00 amRNSAGM Presentation
8th Feb 20186:32 pmRNSHolding(s) in Company
8th Feb 20186:31 pmRNSHolding(s) in Company
5th Feb 201810:01 amRNSHolding(s) in Company
2nd Feb 201811:57 amRNSDirector/PDMR and PCA Shareholding
31st Jan 20185:48 pmRNSTotal Voting Rights
19th Jan 20187:00 amRNSCompletion of the acquisition
15th Jan 20187:00 amRNSIssuance of shares and Acquisition update
9th Jan 20187:00 amRNSAUM update
19th Dec 20177:00 amRNSNotice of Annual General Meeting ("AGM")
11th Dec 20175:00 pmRNSChange of Registered Office
1st Dec 20175:07 pmRNSDirector / PDMR disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.